Among these firms, only 1% say that they are very likely to begin covering GLP-1 agonists for weight loss within the next 12 months, 24% say that they were somewhat likely, 67% say that they were not likely, and 8% do not know the answer to the question [Figure 13.21]
Patients with pre-existing cardiovascular conditions should discuss appropriate monitoring with their prescribing provider
No prior authorization request, step therapy appeal, or forced fail first attempts
For a complete visual walkthrough, see Peptide Injections: Complete Guide
Swelling or tenderness in the legs, which could suggest a blood clot Pain that steadily worsens over time rather than improving Fever that accompanies muscle pain Any symptoms that feel severe or out of the ordinary for you GLP-1 medications also carry a boxed warning regarding a potential risk of thyroid C-cell tumors, including medullary thyroid carcinoma
As soon as one notices anything strange or severe regarding their health condition possibly associated with the injections they should consult a healthcare provider for guidance about this matter early on because we care so much about your safety first of all